Financials
Financial year 2026
Terumo BCT Europe from Zaventem, company number BE0413166055, closed financial year 2026 with a result of € 59.1 million after tax. For that financial year Terumo BCT Europe recorded revenue of € 369.5 million and equity of € 515.9 million. Compared with financial year 2025, the result moved from € 60.8 million to € 59.1 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 8, 2026.
€ 515.9 million
▲ 13% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 59.1 million
▼ 3% vs 2025
Profit after tax over the fiscal year.
€ 53.9 million
▲ 171% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 389.6 million.
People and assets in 2026
271
▲ 10.4 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 45.9 million
▲ 11% vs 2025
€ 169,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 132,313
▲ 6% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 31.7 million
▼ 34% vs 2025
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 38 days on average.
€ 14.7 million
▼ 4% vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 322,889,907 | € 335,916,550 | € 347,394,920 | € 369,493,474 | ▲ 6% |
| Profit after taxes | € 91,408,686 | € 80,541,998 | € 60,844,010 | € 59,088,613 | ▼ 3% |
| Equity | € 315,438,138 | € 395,980,136 | € 456,824,146 | € 515,912,759 | ▲ 13% |
| Total debts | € 76,720,931 | € 74,426,715 | € 79,135,375 | € 71,974,339 | ▼ 9% |
| Cash | € 26,550,222 | € 15,503,690 | € 19,894,019 | € 53,870,054 | ▲ 171% |
| Retained profit | € 189,118,240 | € 269,660,238 | € 330,504,248 | € 389,592,861 | ▲ 18% |
| Dividend | € 40,000,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 394,089,215 | € 472,675,622 | € 538,730,410 | € 590,291,702 | ▲ 10% |
| Employees (FTE) | 259.6 | 255.3 | 260.6 | 271 | ▲ 10.4 |
By revenue, Terumo BCT Europe ranks 1st of 20 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Zaventem that publish figures (fiscal year 2026).
Key figures of Terumo BCT Europe, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about Terumo BCT Europe the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Terumo BCT Europe?
What happened at Terumo BCT Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Mark Ingebritson stepped down as director. NBB
- Sylvain Lacomble stepped down as director. NBB
- KOEN BEERNAERT stepped down as director. NBB
- New annual accounts for financial year 2026: profit of € 59.1 million (▼ 3% vs 2025). Source: NBB ↗
- Anne-Sophie Bricca stepped down as director. NBB
- Mark Ingebritson became a director. NBB
- Sylvain Lacomble became a director. NBB
- KOEN BEERNAERT became a director. NBB
In short
From € 91.4 million profit in 2023 to € 59.1 million profit in 2026.
Paid € 22.8 million in corporate taxes since 2023.
Best year ever: 2023, with € 91.4 million profit.
Paid out € 40 million in dividends to the owners in total.
Management
The shares are held by Terumo BCT Inc (52.9%) and Terumo Corporation (47.1%). It owns 200% of Terumo BCT Espana SL, 100% of Terumo BCT Italia srl, 100% of Terumo BCT Polska Spólka Z Ograniczona Odpowiedzialnoscia , 100% of Terumo BCT Tibbi Cihazlar Dagitimve Hizmetleri A.S. , 100% of Terumo BCT Vietnam and 100% of CaridianBCT Canada Inc itself.
Directors
According to the 2026 annual accounts
Mark Ingebritson
Director
since 2024 · until 2030
Sylvain Lacomble
Director
since 2024 · until 2030
KOEN BEERNAERT
Managing director
since 2024 · until 2030
Anne-Sophie Bricca
Director
since 2024 · until 2026
Shareholders
Terumo BCT Inc
52.9%
Terumo Corporation
47.1%
Participations
Terumo BCT Espana SL
200%
Terumo BCT Italia srl
100%
Terumo BCT Polska Spólka Z Ograniczona Odpowiedzialnoscia
100%
Terumo BCT Tibbi Cihazlar Dagitimve Hizmetleri A.S.
100%
Terumo BCT Vietnam
100%
CaridianBCT Canada Inc
100%
Terumo BCT Kenya Ltd
100%
Terumo BCT Australia Pty Ltd
100%
Terumo BCT Portugal, Unipessoal
100%
Terumo BCT Chile SA
100%
Terumo BCT Hong Kong Ltd
100%
Terumo BCT Egypt for Services
100%
Terumo BCT Uruguay
100%
Terumo BCT Ltd
100%
Terumo BCT Asia
100%
Terumo BCT Japan Inc
100%
Terumo BCT Mexico
100%
Terumo BCT del Peru SAC
100%
Terumo BCT Latin America sa
100%
Terumo BCT Tecnologica Medica
99.8%
Terumo BCT Colombia
94.2%
Establishments
Establishment units
Physical locations of this company
Ikaroslaan 41
1930 Zaventem
Romeinse straat 8
3001 Leuven
Active since 1 April 2013
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Zaventem
Same main activity (Groothandel in farmaceutische en medische artikelen), 23 active companies in Zaventem, largest first.
€ 207.4 million revenue · 2026
€ 169.1 million revenue · 2025
€ 85.5 million revenue · 2025
€ 80.6 million revenue · 2025
€ 70.3 million revenue · 2025
€ 61.8 million revenue · 2025
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
FASTLY - Fastly, Inc., US
Domain
Domain
terumobct.com
Registered
2011-03-10
Registrar
Network Solutions, LLC
Expires
2028-03-10
Website info
Features
Security
Network
Details
- Company number
- 0413.166.055
- VAT number
- BE 0413.166.055
- Registered office
- Ikaroslaan 41, 1930 Zaventem
- Names & denominations
- Terumo BCT Europe
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 May 1973
- Peppol
- Active · Active since 20 Nov 2020
- Contact
- terumobct.com
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten